Neuropsychological and Behavioral Testing in Young Patients With Cancer

Status: Recruiting
Phase: N/A
Diagnosis: Pediatric Brain Tumor
NCT ID: NCT00772200 (View complete trial on ClinicalTrials.gov)
DFCI Protocol ID: 08-363

 

This clinical trial is studying neuropsychological and behavioral testing in young patients with cancer. Collecting information over time from a series of tests may help doctors develop effective tests to measure neuropsychological and behavioral function in young patients with cancer.

 

Conducting Institutions:
Dana-Farber Cancer Institute, Children's Hospital Boston, Massachusetts General Hospital

Overall PI:
Peter Manley, MD, Dana-Farber Cancer Institute

Site-responsible Investigators:

Contacts:
Dana-Farber Cancer Institute: Childrens Hospital Pediatric Clinical Translation Investigation Program CTIP, ctip@partners.org

Eligibility Criteria

DISEASE CHARACTERISTICS: - Histologically confirmed diagnosis of medulloblastoma or supratentorial primitive neuroectodermal tumor (PNET) - Must be currently enrolled on COG-ACNS0331 or COG-ACNS0332 that aims to examine neuropsychological, social, emotional, and/or behavioral functioning PATIENT CHARACTERISTICS: - Must have receptive and expressive English language skills - No history of pre-existing neurodevelopmental disorder (e.g., traumatic brain injury, mental retardation, or Down syndrome) prior to diagnosis of childhood cancer - No history of birth weight < 1,500 g (associated with neuropsychological deficits) PRIOR CONCURRENT THERAPY: - See Disease Characteristics
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms